Dunne Michael W. 4
4 · Iterum Therapeutics plc · Filed Jan 4, 2023
Insider Transaction Report
Form 4
Dunne Michael W.
Director
Transactions
- Exercise/Conversion
Ordinary Shares
2023-01-01+761→ 36,337 total - Exercise/Conversion
Restricted Share Units
2023-01-01−761→ 0 totalExercise: $0.00→ Ordinary Shares (761 underlying)
Footnotes (3)
- [F1]Restricted share units ("RSUs") converted into ordinary shares on a one-for-one basis upon vesting of the RSUs.
- [F2]On March 25, 2022, the reporting person was granted an award of 11,426 RSUs (the "RSU Grant"), which vested on January 1, 2023.
- [F3]On August 17, 2022 the Issuer effected a 1 for 15 reverse share split (the "Reverse Share Split"). The number of ordinary shares underlying the RSU Grant have been adjusted to reflect the Reverse Share Split.